Skip to main content
Asim K. Bag, MBBS, MD, EDiNR
Asim K. Bag, MBBS, MD, EDiNR

Asim K. Bag, MBBS, MD, EDiNR

Associate Member, St. Jude Faculty

  • Interim Director, Neuroimaging Section



MBBS, MD – Medical College Calcutta, Kolkata, India
EDiNR – European Diploma in Neuroradiology
Residency – Medical College Calcutta, Kolkata, India
Neuroradiology Fellowship – UAB School of Medicine, Birmingham, Alabama
Nuclear Medicine Fellowship – UAB School of Medicine, Birmingham, Alabama

Research Interests

  • Response assessment of immunotherapy and radiation therapy
  • MR sequence optimization
  • Imaging of hippocampus mediated memory function

Selected Publications

Alom Z, Tran Q, Bag AK, Lucas JT, Orr BA. Predicting methylation class from diffusely infiltrating adult gliomas using multi-modality MRI data. (Provisionally accepted Adv. in Neuro-Oncology)

Rogers SN, Udayasankar U, Pruthi S, Lai HA, Kadom N, Guerin J, Malinzak M, Shulkin BL, Poussaint TY, Patay Z, Bag AK. Imaging of Pediatric Spine and Spinal Cord Tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee/ASPNR White Paper. Pediatr Blood Cancer Jun 2023; 70 Suppl 4(Suppl 4): e30150. PMID: 36562555. PMCID: PMC10681366 (available on 2024-06-01). doi: 10.1002/pbc.30150 Epub 2022 Dec 23.

Epperly R, Shulkin BLBag AK, Cheng C, Inaba H, Lucas JT, Naik S, Triplett BM, Gottschalk S, Talleur AC. CD19 CAR T-cell therapy demonstrates activity against extramedullary disease in pediatric patients with B-ALL. Blood Adv Oct 24, 2023;7(20):6320-6324. doi: 10.1182/bloodadvances.2023010461. PMID: 37595052; PMCID: PMC10589782.

Li X, Moreira DC, Bag AK, Qaddoumi I, Acharya S, Chiang J. The clinical and molecular characteristics of progressive hypothalamic/optic pathway pilocytic astrocytoma.  Neuro Oncol Apr 6, 2023; 25(4):750-760. doi: 10.1093/neuonc/noac241. PMID: 36260562.

Bernstock JD, Gary SE, Klinger N, Valdes PA, Ibn Essayed W, Olsen HE, Chagoya G, Elsayed G, Yamashita D, Schuss P, Gessler FA, Paolo Peruzzi P, Bag AK, Friedman GK. Standard clinical approaches and emerging modalities for glioblastoma imaging. Neurooncol Adv. May 26, 2022;4(1):vdac080. doi: 10.1093/noajnl/vdac080. PMID: 35821676; PMCID: PMC9268747.

Ghajar-Rahimi G, Kang KD, Totsch SK, Gary S, Rocco A, Blitz S, Kachurak K, Chambers MR, Li R, Beierle E, Bag A, Johnston JM, Markert JM, Bernstock JD, Friedman GK. Clinical advances in oncolytic virotherapy for pediatric brain tumors. Pharmacol Ther Nov 2022: 239:108193. doi: 10.1016/j.pharmthera.2022.108193. PMID: 35487285.

Bag AK, Wing MN, Sabin ND, Hwang SN, Armstrong GT, Han Y, Li Y, Snyder S, Robinson GW, Qaddoumi I, Broniscer A, Lucas JT, Shulkin BL. [11C]-Methionine PET for Identification of Pediatric High[1]Grade Glioma Recurrence. J Nucl Med May 2022; 63(5):664-671. doi: 10.2967/jnumed.120.261891. PMID: 34446453.

Bag AK, Chiang J, Patay Z. Radiohistogenomics of Pediatric Low-Grade Neuroepithelial Tumors. Neuroradiology. Aug 2021;63(8):1185-1213. doi: 10.1007/s00234-021-02691-1.  PMID:33779771. PMCID: PMC8295117.

Friedman GK, Johnston JM, Bag AK, Bernstock JD, et al. Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas. N Engl J Med. 2021 Apr 29;384(17):1613-1622. doi: 10.1056/NEJMoa2024947. Epub Apr 10, 2021. PMID: 33838625. PMCID: PMC8284840.

Last update: March 2024